Neuronetics Appoints Nir Naor as Chief Financial Officer
Neuronetics, Inc. (NASDAQ: STIM), a neurostimulation medical device company, appointed Nir Naor as its new CFO on September 28, 2026. The appointment follows prior SEC inquiries regarding delayed financial filings, underscoring the need for strengthened financial governance and regulatory compliance.
51CFO view：For Chinese companies facing SEC inquiries or filing delays, the CFO must possess: (1) proven experience managing Nasdaq/SEC disclosure crises; (2) hands-on ASC 606 revenue recognition and ASC 730 R&D capitalization expertise in medtech; and (3) ability to rebuild reporting cycles and satisfy SOX 302/404 certification requirements.
Neuronetics, Inc. (NASDAQ: STIM), a neurostimulation medical device company, appointed Nir Naor as its new CFO on September 28, 2026. The appointment follows prior SEC inquiries regarding delayed financial filings, underscoring the need for strengthened financial governance and regulatory compliance.
Source：Google News · CFO 任命
Why this matters to your CFO search
Where this touches your finance hire
Every listing event changes what you need from a CFO. Start from the step you are actually at.
How is a US-listed CFO paid?
Base, equity incentive and listing-milestone bonus: structure and ranges.
Read →
Who owns SEC reporting and US GAAP?
Signature responsibility for 10-K / 10-Q / 8-K / 20-F, and common comments.
Read →
What kind of CFO does a US IPO need?
S-1 / F-1 filing, US GAAP conversion, roadshow — the hard requirements.
Read →